ESTRELLA IMMUNOPHARMA, INC. Interest Income, Deposits with Financial Institutions
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Interest Income, Deposits with Financial Institutions of $100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeDepositsWithFinancialInstitutions · last filed 2026-08-13
- ESTRELLA IMMUNOPHARMA, INC. interest income, deposits with financial institutions for the quarter ending 2026-06-30 was -$1.80M.
- ESTRELLA IMMUNOPHARMA, INC. interest income, deposits with financial institutions for the quarter ending 2026-03-31 was $1.90M.
- ESTRELLA IMMUNOPHARMA, INC. interest income, deposits with financial institutions for the quarter ending 2024-09-30 was $1.40M.
- ESTRELLA IMMUNOPHARMA, INC. interest income, deposits with financial institutions for the quarter ending 2023-06-30 was $2.23M.
- ESTRELLA IMMUNOPHARMA, INC. interest income, deposits with financial institutions for fiscal 2023 was $2.23M.
| Period end | Interest Income, Deposits with Financial Institutions 3 month | Interest Income, Deposits with Financial Institutions 6 month | Interest Income, Deposits with Financial Institutions 12 month | Interest Income, Deposits with Financial Institutions 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $100.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-18 | |||
| 2025-12-31 | $1.40M 10-Q · filed 2026-08-13 | |||
| 2024-09-30 | $1.40M 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $3.80M 10-Q · filed 2024-11-14 | $3.76M 10-K · filed 2024-09-27 | ||
| 2023-12-31 | $8.78M 10-Q · filed 2024-02-14 | |||
| 2023-06-30 | $2.23M 10-Q · filed 2024-02-14 | $2.23M 10-K · filed 2024-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |